Invesco India Contra Fund: Beating the Markets with Its Contrarian Bets

While there has been a rally across market cap segments, with most of the stocks and sectors moving up significantly, there are still several fundamentally sound stocks and sectors that are temporarily discarded by investors and are available at a deep discount to their fair value. The key is to timely identify such stocks and sectors and stay put until their full potential is realised.

Contra Funds aim to invest in such cheaply available stocks and out-of-favour sectors that are available at a significant discount to their fair valuation but have the potential to grow significantly. During market highs, such stocks offer a better margin of safety which gives them the potential to generate decent returns over the long run.

But with only three contra-style funds cumulatively managing a corpus of just around Rs 17,167 crore, they are less popular among investors. Among these, Invesco India Contra Fund is currently the largest scheme with an AUM of Rs 9,669 crore. This contra-style fund has done reasonably well in terms of performance and has rewarded its long-term investors with decent gains.

Past performance is not an indicator of future returns
Data as on November 07, 2022
(Source: ACE MF)

Invesco India Contra Fund holds a superior track record and figures in the list of top-quartile performers among diversified equity funds over the longer time periods recorded in the past. It has distinctly outperformed the benchmark S&P BSE 500 - TRI across time periods. Notably, in the last 3-year, 5-year, and 7-year periods, the fund has managed to generate a decent alpha of about 1.5-to 2 percentage points over the benchmark. During the market crash of 2020, Invesco India Contra Fund was distinctly ahead of the category average as well as its benchmark. However, it couldn't keep pace during the recovery phase and has marginally trailed the benchmark and its peers, which has adversely impacted its near-term performance.

Invesco India Contra Fund has fared well on risk-reward parameters. The fund has registered lower volatility compared to the benchmark and category peers and has been effective in generating reasonable risk-adjusted returns for its long-term investors. Its Sharpe ratio of 0.21 and Sortino of 0.31 look better compared to its benchmark, though lower than its top-performing peer SBI Contra Fund. The fund has well-compensated its investors for the level of risk taken.

Join Now: PersonalFN is now on Telegram. Join FREE Today to get 'Daily Wealth Letter' and Exclusive Updates on Mutual Funds

Investment strategy of Invesco India Contra Fund

Invesco India Contra Fund is positioned to follow a contrarian investment strategy to timely pick fundamentally sound stocks from sectors that are temporarily out of favour or beaten-down stocks that are available at a significant discount. Accordingly, the fund managers pick 'neglected stocks' with strong asset values while focusing on under-owned sectors carrying high growth potential. The aim is to have a first-mover advantage by investing in out-of-favour sectors/stocks, thus increasing the long-term out-performance prospects.

While investing, the fund managers look for temporarily ignored but fundamentally sound stocks and carry high conviction in their long-term growth potential, holding them in the portfolio until their intrinsic value is achieved. Accordingly, the fund managers identify and invest in potentially undervalued stocks across sectors utilising the 'top-down' and 'bottom-up' approach and believe in incubating such stocks for a while before they find favour with the rest of the market. The fund managers also try to proactively identify new investment themes, examine the play on the relative attractiveness of mid-caps and large-caps, and adjust the market cap of the portfolio towards higher return potential opportunities.

While the fund managers are on a constant hunt for stocks available at cheap valuations and look at timely entry and exit, moderate churning in Invesco India Contra Fund's portfolio cannot be ruled out.

Invesco India Contra Fund usually holds a well-diversified portfolio of 45-55 stocks at any point in time. As of October 31, 2022, the fund held a well-diversified portfolio of about 61 stocks, with the top 10 stock holdings accounting for around 45.4% of its assets. Highly liquid large-cap names like ICICI Bank, HDFC Bank, Infosys, Reliance Industries, and SBI currently appear among the top holdings in the fund's portfolio. Sun Pharma, Axis Bank, L&T, NTPC, and HUL currently stand among the other top holdings in the portfolio. Most of these stocks have been among the core contenders in the fund's portfolio for a long time.

In the last couple of years, Invesco India Contra Fund has benefited immensely from its holdings in stocks like ICICI Bank, HDFC Bank, Infosys, Sun Pharma, Reliance Industries, HCL Technologies, Bharat Electronics, Tech Mahindra, KEI Industries, Cipla, Ultratech Cement, KNR Constructions, etc.

The top 5 sectors in Invesco India Contra Fund's portfolio accounted for around 59.6% of its assets. It holds higher weightage in Banking & Finance, followed by Infotech, Consumption, Pharma, Engineering, and Auto. Petroleum, Power, Cement, Construction, Consumer Durables, and Telecom figure among the other prominent sectors in the fund's portfolio.

The fund's portfolio is diversified across market caps, with around 73% of its assets in large caps, along with 13.5% in midcaps and 9% in small-cap stocks.

Suitability

Invesco India Contra Fund holds a superior long-term performance track record and has the ability to deliver market-beating returns over longer time periods. It follows a contrarian investment strategy to timely pick fundamentally sound stocks from sectors that are temporarily out of favour or beaten-down stocks that are available at a significant discount.

During the 2020 market crash, Invesco India Contra Fund took advantage of picking beaten-down fundamentally sound stocks at attractive price points. But as the growth sentiment kicked in, this Contra Fund suffered in performance as it couldn't participate and fully capitalise on the swift market recovery. Nevertheless, the fund has the potential to bounce back strongly.

Invesco India Contra Fund is suitable for investors with a high risk appetite and seeking exposure in an actively managed Contra Fund with an investment horizon of at least 5-7 years. As Contra Funds invest in 'out-of-favour' themes, they may temporarily underperform in the short term and hence deserve patience.

Warm Regards,
Vivek Chaurasia
Editor, FundSelect

PS: If you are looking for quality mutual fund schemes (including Equity-linked Saving Schemes) to add to your investment portfolio, I suggest you subscribe to PersonalFN's premium research service, FundSelect. PersonalFN's FundSelect service provides insightful and practical guidance on which mutual fund schemes to Buy, Hold, and Sell.

Currently, with the subscription to FundSelect, you could also get Free Bonus access to PersonalFN's Debt Fund recommendation service  DebtSelect.

If you are serious about investing in a rewarding mutual fund scheme, subscribe now!

Note:  This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

1. Money Simplified Services Private Limited;

2. PersonalFN Insurance Services India Private Limited;

3. Equitymaster Agora Research Private Limited;

4. Common Sense Living Private Limited;

5. Quantum Advisors Private Limited;

6. Quantum Asset Management Company Private Limited;

7. HelpYourNGO.com India Private Limited;

8. HelpYourNGO Foundation;

9. Natural Streets for Performing Arts Foundation;

10. Primary Real Estate Advisors Private Limited;

11. HYNGO India Private Limited;

12. Suresh Lulla;

13. I V Subramaniam.

1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company; except one of the Research Analysts holding units of Invesco India Contra Fund.

3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

1. The Research Analyst has not served as an officer, director or employee of the subject Company.

2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013